Bhatia Bhairavi, Singhal Shweta, Jayaram Hari, Khaw Peng T, Limb G Astrid
Division of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK.
Open Ophthalmol J. 2010 Jul 8;4:30-8. doi: 10.2174/1874364101004010030.
Recent advances in retinal stem cell research have raised the possibility that these cells have the potential to be used to repair or regenerate diseased retina. Various cell sources for replacement of retinal neurons have been identified, including embryonic stem cells, the adult ciliary epithelium, adult Müller stem cells and induced pluripotent stem cells (iPS). However, the true stem cell nature of the ciliary epithelium and its possible application in cell therapies has now been questioned, leaving other cell sources to be carefully examined as potential candidates for such therapies. The need for identification of the ontogenetic state of grafted stem cells in order to achieve their successful integration into the murine retina has been recognized. However, it is not known whether the same requirements may apply to achieve transplant cell integration into the adult human eye. In addition, the existence of natural barriers for stem cell transplantation, including microglial accumulation and abnormal extracellular matrix deposition have been demonstrated, suggesting that several obstacles need to be overcome before such therapies may be implemented. This review addresses recent scientific developments in the field and discusses various strategies that may be potentially used to design cell based therapies to treat human retinal disease.
视网膜干细胞研究的最新进展增加了这些细胞可用于修复或再生患病视网膜的可能性。已确定了多种用于替代视网膜神经元的细胞来源,包括胚胎干细胞、成年睫状体上皮、成年穆勒干细胞和诱导多能干细胞(iPS)。然而,睫状体上皮的真正干细胞性质及其在细胞治疗中的可能应用现在受到了质疑,其他细胞来源作为此类治疗的潜在候选者有待仔细研究。人们已经认识到,为了使移植的干细胞成功整合到小鼠视网膜中,需要确定其个体发育状态。然而,尚不清楚实现移植细胞整合到成年人类眼中是否需要同样的条件。此外,已经证明了干细胞移植存在天然屏障,包括小胶质细胞积聚和细胞外基质异常沉积,这表明在实施此类治疗之前需要克服几个障碍。本综述阐述了该领域的最新科学进展,并讨论了可能用于设计基于细胞的疗法来治疗人类视网膜疾病的各种策略。